AGR2 associates with HER2 expression predicting poor outcome in subset of estrogen receptor negative breast cancer patients.
Sign Up to like & getrecommendations! Published in 2017 at "Experimental and molecular pathology"
DOI: 10.1016/j.yexmp.2017.02.016
Abstract: Expression of the AGR2 oncogene was shown to be associated with estrogen receptor positive tumors. This gene contributes to enhanced cellular proliferation, drug resistance, metastasis development and may also serve as a predictor of poor… read more here.
Keywords: subset estrogen; estrogen; receptor negative; expression ... See more keywords